... Last reviewed dd mmm yyyy. Last edited dd mmm yyyy ...

"Karnofsky Performance Status" by people in UAMS Profiles by year, and whether "Karnofsky Performance Status" was a major or ... "Karnofsky Performance Status" is a descriptor in the National Library of Medicines controlled vocabulary thesaurus, MeSH ( ... Below are the most recent publications written about "Karnofsky Performance Status" by people in Profiles over the past ten ... Karnofsky Performance Status*Karnofsky Performance Status. *Performance Status, Karnofsky. *Status, Karnofsky Performance ...

Mappings for the mcode-karnofsky-performance-status resource profile.. Mappings for Workflow Pattern (http://hl7.org/fhir/ ... status. status Amended & Final are differentiated by whether it is the subject of a ControlAct event with a type of revise. ...

... the Karnofsky performance status, (4) the EuroQol visual analog scale, and (5) the Nottingham health profile. This pilot study ...

Karnofsky performance status less than 60. Extensive stage disease. Cerny, T; Blair V; Anderson H; et al. (1987). "Pretreatment ...

Karnofsky Performance Status. Systemic Disease. Median Survival, mo. Age 65 y or younger ... Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions. Future Oncol. 2012 ...

Demographic information including age, Karnofsky Performance Status (KPS), gender, and primary cancer sites were collected. ...

Karnofsky Performance Status. Systemic Disease. Median Survival, mo. Age 65 y or younger ... Systemic treatment of brain metastases in HER2-positive breast cancer: current status and future directions. Future Oncol. 2012 ... Causes global CNS depression, presumably through agonist actions of GABA receptors; Indicated for treatment of status ... Indicated for status epilepticus as complication of disease ...

Karnofsky performance status ≥60; absence of active central nervous system lesions, and no changes to their antihypertensive ... Verify pregnancy status in females of reproductive potential prior to initiating AZEDRA [see Use in Specific Populations (8.1)] ... Verify pregnancy status in females of reproductive potential prior to initiating AZEDRA [see Dosage and Administration (2.1)]. ... Verify pregnancy status in females of reproductive potential prior to initiating AZEDRA [see Use in Specific Populations (8.1 ...

Karnofsky performance status < 80%. *Neutrophil count > ULN. *Platelet count > ULN. *No radiographic evidence of cavitating ... Performance status: Eastern Cooperative Oncology Group (ECOG) 0-2. *Archival tissue must be available for submission, though it ... Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation ...

Eastern Cooperative Oncology Group (ECOG) score of 0 or 1; or Karnofsky Performance Status (KPS) of ≥ 70%. ...

5. Karnofsky performance status ≥ 70. 6. Life expectancy ≥ least 3 months. 7. Participants of childbearing age must use highly ...

Performance status: Karnofsky >/= 60% for 12 to >/= 60% for 1 to < 12 years of age.. - Adequate hematologic function.. - ... Dementia, altered mental status, or any other medical condition or disorder that. would prohibit the understanding or rendering ...

A Karnofsky performance status of less than 70. Other HIV-related illness is present, for example, neurological disease or ... Immune system (I): The status of the immune system, which is measured by the number of a specific type of white blood cell, ... Aggressive lymphomas are also evaluated based on the International Prognostic Index and functional status. Learn more about ...

Karnofsky performance status was assessed at each follow-up, and clinical symptoms and signs of tumor progression were closely ... patients Karnofsky performance status greater than 70%; 4) previous chemotherapy limited to nonplatinum agents; 5) no prior ... During therapy, follow-up imaging was performed every 2 to 3 months depending on the clinical status of the patient. The ... In our study, the perfusion data corresponded much better with the actual clinical status of the patient than did conventional ...

2. Decreased performance status as measured by the Karnofsky Performance Status (KPS) scale, of ≤ 50.. 3. Documentation of the ... 2. Documentation certifying terminal status must contain enough information to confirm terminal status upon review. ... Karnofsky DA, Burchenal JH. The clinical evaluation of chemotherapeutic agents in cancer. In: MacLeod CM, ed. Evaluation of ... sufficient documentation of the patients condition that justifies terminal status, in the absence of meeting the above ...

5. Karnofsky Performance Status score ≥ 70. 6. Age > 19 years-old. 7. Capable of giving informed consent. 8. Must be willing to ...

ECOG performance status ≤2 (Karnofsky ≥60%, see Appendix A). *Ability and willingness to comply with the study procedures. ...

Karnofsky or Lansky performance status (PS): performance status of >= 50 assessed within two weeks prior to registration; ... will be considered ambulatory for the purpose of assessing the performance score ...

... a Karnofsky performance status score of ≥60, and acceptable hematologic, liver, and renal function. The latter required an ... and median Karnofsky performance status score of 80 (range, 60-100). Twenty-six patients had glioblastomas, five had anaplastic ... and determination of Karnofsky performance status was done every other cycle. Complete blood counts, including differential and ... Stable disease was defined by a clinical status and radiographic tumor measurements that did not meet the criteria for CR, PR, ...

Poor performance status - Eastern Cooperative Oncology Group (ECOG) score ≥3 or Karnofsky Performance Status (KPS) score ≤50 ... Indicators of a potential benefit are ECOG/WHO performance score 0-2, a low level of systemic inflammation (normal levels of ... Managing symptoms, distress, and functional status (eg, pain, dyspnea, fatigue, sleep disturbance, mood, nausea, constipation) ... especially with changes in disease status (ie, remission, recurrence, or disease progression). ...

Karnofsky performance status ≥ 60% performed within a 14-day window prior to. randomization. ... Karnofsky performance status ≥ 70% performed within a 14-day window prior to. randomization. ...

Karnofsky performance status score is ≥70 (ie, patient is up and about most of the time and able to take care of him- or ... Karnofsky performance status score is ≥70 (ie, patient is up and about most of the time and able to take care of him- or ... 4] (with subsequent modifications). The ACTG system uses three variables: tumor extent (T), immune status (I), and systemic ... while tumor status was most predictive of death in the 4-24 month period. [5] ...

Lansky/Karnofsky performance status ≥ 60 Organ and marrow function as defined below: ...

Karnofsky performance status score (KPS score)≥70; normal function of heart, liver, kidney, and other important organs and ... The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol 2003;56:1129-35. ...

Karnofsky performance status ≥50. For infants and children less than 12 years of age, the Lansky play scale ≥50% will be used. ... The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU ... Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, ...

Karnofsky Performance Status Score Assesses patient for functional impairment. Kawasaki Disease Diagnostic Criteria Diagnostic ...

The relationship between two performance scales: New York Heart Association Classification and Karnofsky Performance Status ... antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats. Fundam. Clin. Pharmacol. 2007, 21, ... ameliorating the functional status (higher Karnofski Scale Index) and the symptoms (lower WOMAC (Western Ontario and McMaster ... extracellular matrix degrading enzymes and antioxidant status. Eur. J. Nutr. 2013, 52, 1787-1799. [Google Scholar] [CrossRef] [ ...

... comprising Karnofsky performance status , 80% vs ≥ 80% and the presence of visceral metastases [0 vs 1 vs 2 or liver metastases ... Randomization was stratified by PD-L1 immune cell expression status of , 1% vs ≥ 1% and , 5% vs ≥ 5%, Bajorin risk factor score ...

... discriminant validity using the Karnofsky Performance Status scale; and feasibility, with response ratio and required time. ...